Professor Maggie Dallman, OBE, is Vice President (International), Associate Provost (Academic Partnerships) and Professor of Immunology. In her Vice President and Associate Provost roles, Maggie is the academic lead on, respectively, the College's International Relations and Societal Engagement Strategies. For further information view:
Maggie joined Imperial College in 1994 as a lecturer in the Department of Biology, coming from the University of Oxford where she had held a Nuffield Medical Research Foundation Junior Research Fellowship followed by an MRC Senior Research Fellowship. At Imperial College she became Reader in Immunoregulation in 1996 and Professor of Immunology in 1999. Since 2001 Maggie has held a variety of senior positions at Imperial College including Head Section Immunology and Infection, Campus Dean and Deputy Principal for the Faculty of Natural Sciences, becoming Dean of the Faculty in 2008. Maggie took up her most recent roles as Associate Provost (Academic Partnerships) and Vice President (International) in January 2015 and January 2018 respectively. In 2022, Maggie became executive sponsor of i600, Imperial's network for LGBTQplus staff and postgraduate students at Imperial College London in 2022.
Maggie is well known for her work to improve the public understanding of science and technology, especially among those from underserved backgrounds. She is passionate about giving young people from all walks of life the opportunity to reach their potential, believing that education is central in achieving this goal.
Maggie participates in a broad range of external activities including: Member, Royal Society Public Engagement committee; Governor and Trustee, Westminster School, London; Trustee and co-chair, Exhibition Road Cultural Group; Governor, Harris Westminster Sixth Form, London; Chair, International Advisory Panel, Tokyo Tech University.
Research Interests: An ability to generate immune responses to invading pathogens is vital to our well being and survival yet over-vigorous or inappropriate responses can lead to debilitating or life threatening conditions such as autoimmunity (e.g. diabetes, rheumatoid arthritis) and allergy. Further, as our understanding of disease develops we find that dysregulated inflammatory responses are associated with conditions as diverse as alzheimer’s disease and obesity. An understanding of and an ability to control inappropriate immunity and inflammation lie therefore on the path to successful treatment of these varied diseases. Maggie’s own work uses a range of organisms from zebrafish (ZFIN webpage) to humans to study at the molecular, cellular and whole individual level not only the basis for disease but also potential approaches to therapy.
View the Dallman Lab website for further information.
et al., 2023, Sir Peter J. Morris, AC, FRS, FMedSci, FRCP, FRCS, Transplantation, Vol:107, ISSN:0041-1337, Pages:1416-1422
et al., 2023, Modular synthesis of semiconducting graft co-polymers to achieve ‘clickable’ fluorescent nanoparticles with long circulation and specific cancer targeting, Advanced Materials, ISSN:0935-9648, Pages:1-14
et al., 2022, Potent virustatic polymer-lipid nanomimics block viral entry and inhibit malaria parasites in vivo, Acs Central Science, Vol:8, ISSN:2374-7943, Pages:1238-1257
et al., 2020, In vivo biomolecular imaging of zebrafish embryos using confocal Raman spectroscopy, Nature Communications, Vol:11, ISSN:2041-1723, Pages:1-12
et al., 2020, Zebrafish IL-4-like cytokines and IL-10 suppress inflammation but only IL-10 is essential for gill homeostasis, Journal of Immunology, Vol:205, ISSN:0022-1767, Pages:994-1008